Pre-Conference Workshops

Day 1

Expand All Sessions [+] Collapse All Sessions [-]

9:00 AM Practical Aspects of Solubility Determination and Considerations for Enabling Formulation Technologies

Meg Landis , Senior Principal Scientist, Pfizer

Marc Tesconi , Group Lead, Formulation Design, Pfizer

What you will learn:

  • Stage-appropriate methods of measuring solubility

  • Pitfalls in the interpretation of solubility data

  • Solubility considerations for key formulation platforms, including peptides and prodrugs

How you will benefit:

  • Gain appreciation for the limitations of various solubility measurement methods

  • Gain insight to critically interpret and evaluate solubility data

  • Discuss and learn about current industrial strategy and practice

Meg Landis
Senior Principal Scientist
Pfizer

Marc Tesconi
Group Lead, Formulation Design
Pfizer

12:00 PM Ensuring that Poor Oral Bioavailability does not become a Roadblock in Drug Discovery

Rene Holm , Head, Preformulation, H. Lundbeck

Discovery formulations are used in pharmacology studies, ADME, and toxicology evaluations. The challenge for the pharmaceutical scientist is to use the limited exciting physical chemical data, knowledge about general compound behavior and computer models to achieve a formulation strategy that is suited to meet the needs and demands for each of these studies and route of administration – and that’s with a very limited amount of compound available. In vivo experiments are typically conducted with enabling formulations to maximize exposure of frequently low aqueous soluble compounds.

  •  

You will learn:

  • Discuss the importance in formulations for pharmacology, ADME
  • The role of toxicology
  • Options in solubilisation techniques and the obtained experience

You will benefit:

  • How to judiciously choose solubilizing vehicles in order to meet the desired concentration levels
  • Keeping the vehicle should still be inert both pharmacologically and toxicologically
  • The usage of different formulation strategies may change along the discovery process
Rene Holm
Head, Preformulation
H. Lundbeck

3:00 PM Potential Applications of Layer-by-Layer Nano-coating in Drug Delivery

Dedong Wu , Senior Research Scientist, AstraZeneca

Wenzhan Yang , Senior Scientist, AstraZeneca

This workshop highlights Layer-by-Layer surface nanoassembly is a simple method allowing the design of multilayer architectures with nanometer precision. There is great potential for this technology to be adopted in drug delivery.

You will learn:

  • Layer-by-layer nanoassembly
  • Basic principles of the LbL technology
  • Potential application of LbL in drug delivery

You will benefit:

  • A case study of an emerging application to the nanocystals technique is the layer-by-layer coating technique applied to nanoparticles
  • Exploring if coated nanoparticles will not only improve particle stability as well as  offer the possibility of designing nanoparticle surfaces that can achieve controlled release and targeted delivery
Dedong Wu
Senior Research Scientist
AstraZeneca

Wenzhan Yang
Senior Scientist
AstraZeneca

Download the Agenda

Resource Centre

Click here for Downloads

IDGA

Become a Pharma IQ Member and receive our weekly newsletter!

Quick Links